Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/ICO.0000000000002761 http://scihub22266oqcxt.onion/10.1097/ICO.0000000000002761 34029238!8244807!34029238     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cornea 2021 ; 40 (8): 1070-1072 Nephropedia Template TP {{tp|p=34029238|t=2021. Keratoplasty Rejection After the BNT162b2 messenger RNA Vaccine |pdf=|usr=}}{{34029238}} gab.com Text Keratoplasty Rejection After the BNT162b2 messenger RNA Vaccine JO: Cornea http://www.kidney.de/pget.php?&tw=1&pmid=34029238 #FOAvip PURPOSE: The aim of this report was to report 2 patients who presented with acute corneal graft rejection 2 weeks after receiving the BNT162b2 messenger RNA (mRNA) vaccine for severe acute respiratory syndrome coronavirus 2. METHODS: Case report. RESULTS: Two men, aged 73 and 56 years, with a history of penetrating keratoplasty due to keratoconus were noted to have acute corneal graft rejection 2 weeks after receiving a first dose of the BNT162b2 mRNA vaccine. Both patients were treated with hourly dexamethasone 0.1% and oral prednisone 60 mg per day with prompt resolution of keratoplasty rejection. CONCLUSIONS: The BNT162b2 mRNA vaccine may be have been associated with a low-risk corneal graft rejection that responded well to topical and systemic steroids. Treating physicians should be aware of this potential complication and patients should be advised to report any visual changes after vaccination. Twit Text FOAVip Keratoplasty Rejection After the BNT162b2 messenger RNA Vaccine ????Cornea http://www.kidney.de/pget.php?&tw=1&pmid=34029238 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34029238 #FOAvip English Wikipedia <ref>{{Cite pmid|34029238}}</ref> Keratoplasty Rejection After the BNT162b2 messenger RNA Vaccine #MMPMID34029238 Wasser LM; Roditi E; Zadok D; Berkowitz L; Weill Y Cornea 2021[Aug]; 40 (8): 1070-1072 PMID34029238show ga PURPOSE: The aim of this report was to report 2 patients who presented with acute corneal graft rejection 2 weeks after receiving the BNT162b2 messenger RNA (mRNA) vaccine for severe acute respiratory syndrome coronavirus 2. METHODS: Case report. RESULTS: Two men, aged 73 and 56 years, with a history of penetrating keratoplasty due to keratoconus were noted to have acute corneal graft rejection 2 weeks after receiving a first dose of the BNT162b2 mRNA vaccine. Both patients were treated with hourly dexamethasone 0.1% and oral prednisone 60 mg per day with prompt resolution of keratoplasty rejection. CONCLUSIONS: The BNT162b2 mRNA vaccine may be have been associated with a low-risk corneal graft rejection that responded well to topical and systemic steroids. Treating physicians should be aware of this potential complication and patients should be advised to report any visual changes after vaccination. |*Keratoplasty, Penetrating[MESH] |*SARS-CoV-2[MESH] |Acute Disease[MESH] |Administration, Ophthalmic[MESH] |Administration, Oral[MESH] |Aged[MESH] |BNT162 Vaccine[MESH] |COVID-19 Testing[MESH] |COVID-19 Vaccines/*adverse effects[MESH] |COVID-19/*prevention & control[MESH] |Dexamethasone/therapeutic use[MESH] |Graft Rejection/drug therapy/*etiology[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Prednisone/therapeutic use[MESH] |Vaccines, Synthetic/*adverse effects[MESH]Keratoplasty Rejection After the BNT162b2 messenger RNA Vaccine (epmc).pdf DeepDyve Pubget Overpricing